Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial
Horst Olschewski(Sigmund Freud Privatuniversität Wien), Thomas Schmehl(Saarland University), Werner Seeger(Justus-Liebig-Universität Gießen), F. X. Kleber(Saarland University), Jürgen Behr(Ludwig-Maximilians-Universität München), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Jörg Winkler(University Hospital Leipzig), Heinrike Wilkens(Saarland University), Marius M. Höper(Saarland University)
Cited by 287
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784